153 related articles for article (PubMed ID: 19175047)
1. [Progress in gynecological endocrinology].
Skałba P
Ginekol Pol; 2008 Dec; 79(12):877-81. PubMed ID: 19175047
[TBL] [Abstract][Full Text] [Related]
2. The polycystic ovary syndrome: a position statement from the Polish Society of Endocrinology, the Polish Society of Gynaecologists and Obstetricians, and the Polish Society of Gynaecological Endocrinology.
Milewicz A; Kudła M; Spaczyński RZ; Dębski R; Męczekalski B; Wielgoś M; Ruchała M; Małecka-Tendera E; Kos-Kudła B; Jędrzejuk D; Zachurzok A
Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209800
[TBL] [Abstract][Full Text] [Related]
3. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
[TBL] [Abstract][Full Text] [Related]
4. Secondary forms of polycystic ovary syndrome.
Kaltsas GA; Isidori AM; Besser GM; Grossman AB
Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
[TBL] [Abstract][Full Text] [Related]
5. Clinical observations and hormone screenings of patients with non-standard hypertrophy of the adrenal cortex.
Franik G; Skałba P
Endokrynol Pol; 2011; 62(3):230-7. PubMed ID: 21717405
[TBL] [Abstract][Full Text] [Related]
6. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
7. How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.
Moghetti P; Carmina E; De Leo V; Lanzone A; Orio F; Pasquali R; Toscano V
J Endocrinol Invest; 2015 Sep; 38(9):1025-37. PubMed ID: 25835559
[No Abstract] [Full Text] [Related]
8. A twenty-first century research agenda for polycystic ovary syndrome.
Legro RS; Azziz R; Giudice L
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):331-6. PubMed ID: 16772161
[TBL] [Abstract][Full Text] [Related]
9. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
10. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
11. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
13. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
J Clin Endocrinol Metab; 2006 Nov; 91(11):4237-45. PubMed ID: 16940456
[TBL] [Abstract][Full Text] [Related]
14. [National consensus on hyperandrogenemia].
Aganović I; Alac M; Cabrijan T; Grizelj V; Korsić M; Misjak-Vitez M; Reiner Z; Suchanek E; Simunić V; Zjacić-Rotkvić V
Lijec Vjesn; 1996 Sep; 118(9):189-90. PubMed ID: 9011736
[TBL] [Abstract][Full Text] [Related]
15. MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects.
Pasquali R; Diamanti-Kandarakis E; Gambineri A
Eur J Endocrinol; 2016 Oct; 175(4):R157-69. PubMed ID: 27170519
[TBL] [Abstract][Full Text] [Related]
16. [Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia].
Halperin Rabinovich I; Cámara Gómez R; García Mouriz M; Ollero García-Agulló D;
Endocrinol Nutr; 2013; 60(6):308-19. PubMed ID: 23477758
[TBL] [Abstract][Full Text] [Related]
17. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome: a common but often unrecognized condition.
Shannon M; Wang Y
J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
[TBL] [Abstract][Full Text] [Related]
19. [Highlights of the sixth national gynecological endocrinology summit of the Chinese Medical Association].
Shi YH; Tian QJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):564-6. PubMed ID: 21029608
[No Abstract] [Full Text] [Related]
20. Updates in pediatric endocrinology.
Kamboj MK
Adolesc Med State Art Rev; 2013 Apr; 24(1):108-32, xii. PubMed ID: 23705521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
